On January 31, 2022, Ronald W. Barrett, Independent Director notified Concert Pharmaceuticals, Inc. that he will not stand for re-election at the company's 2022 Annual Meeting of Stockholders. Dr. Barrett's decision to not stand for re-election was personal and not related to any disagreement with the company on any matter relating to its operations, policies or practices.
Concert Pharmaceuticals, Inc.
Equities
CNCE
US2060221056
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+51.99% | 55.7B | |
+40.60% | 39.91B | |
-6.43% | 39.57B | |
-5.56% | 28.16B | |
+15.18% | 26.3B | |
-20.39% | 18.94B | |
+31.65% | 12.17B | |
+27.10% | 12.12B | |
+0.56% | 12.12B |